(Q38864194)

7 September 2017

1 reference

title

Short Anabolic Peptides for Bone Growth (English)

1 reference

7 September 2017

Zaid Amso

1

0 references

Margaret Brimble

series ordinal

3

object named as

Margaret A Brimble

1 reference

7 September 2017

2

Jillian Cornish

1 reference

7 September 2017

28 March 2016

1 reference

Medicinal Research Reviews

7 September 2017

1 reference

7 September 2017

36

1 reference

7 September 2017

4

1 reference

7 September 2017

579-640

1 reference

New understanding and treatments for osteoporosis

7 September 2017

1 reference

Osteoporosis: impact on health and economics

21 January 2018

1 reference

Osteoporosis: now and the future

21 January 2018

1 reference

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

21 January 2018

1 reference

Anti-resorptive therapies for osteoporosis.

21 January 2018

1 reference

Parathyroid hormone analogues in the treatment of osteoporosis

21 January 2018

1 reference

Short-term and long-term effects of osteoporosis therapies.

21 January 2018

1 reference

Efficacy, effectiveness and side effects of medications used to prevent fractures.

21 January 2018

1 reference

The future of peptide-based drugs

21 January 2018

1 reference

Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH.

21 January 2018

1 reference

Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives

21 January 2018

1 reference

Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis

21 January 2018

1 reference

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism

21 January 2018

1 reference

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

Teriparatide: a review of its use in osteoporosis.

21 January 2018

1 reference

Parathyroid hormone for the treatment of osteoporosis: a systematic review

21 January 2018

1 reference

Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label ph

21 January 2018

1 reference

The anabolic effects of parathyroid hormone therapy

21 January 2018

1 reference

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

21 January 2018

1 reference

Update in new anabolic therapies for osteoporosis

21 January 2018

1 reference

Single and combined use of human parathyroid hormone (PTH) (1-34) on areal bone mineral density (aBMD) in postmenopausal women with osteoporosis: evidence based on 9 RCTs

21 January 2018

1 reference

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis

21 January 2018

1 reference

Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose

21 January 2018

1 reference

Safety of parathyroid hormone for the treatment of osteoporosis

21 January 2018

1 reference

Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis

21 January 2018

1 reference

Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide, hPTH(1-34), on Bone Formation and Resorption in Ovariectomized Rats

21 January 2018

1 reference

Monthly administration of a novel PTH-collagen binding domain fusion protein is anabolic in mice

21 January 2018

1 reference

A single injection of the anabolic bone agent, parathyroid hormone-collagen binding domain (PTH-CBD), results in sustained increases in bone mineral density for up to 12 months in normal female mice.

21 January 2018

1 reference

Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis

21 January 2018

1 reference

Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women

21 January 2018

1 reference

First-in-human testing of a wirelessly controlled drug delivery microchip.

21 January 2018

1 reference

Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis

21 January 2018

1 reference

Developmental regulation of the growth plate

21 January 2018

1 reference

A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study

21 January 2018

1 reference

Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.

21 January 2018

1 reference

Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications

21 January 2018

1 reference

Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial.

21 January 2018

1 reference

TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility

21 January 2018

1 reference

21 January 2018

1 reference

The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications

21 January 2018

1 reference

Accelerated bone repair with the use of a synthetic BMP-2-derived peptide and bone-marrow stromal cells.

21 January 2018

1 reference

Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide.

21 January 2018

1 reference

Experimental research on ectopic osteogenesis of BMP2-derived peptide P24 combined with PLGA copolymers.

21 January 2018

1 reference

Preparation and ectopic osteogenesis in vivo of scaffold based on mineralized recombinant human-like collagen loaded with synthetic BMP-2-derived peptide

21 January 2018

1 reference

Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro.

21 January 2018

1 reference

Bone induction by biomimetic PLGA-(PEG-ASP)n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo

21 January 2018

1 reference

The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone.

21 January 2018

1 reference

Osteogenesis induced by a bone forming peptide from the prodomain region of BMP-7.

21 January 2018

1 reference

Increased osteoblast functions in the presence of BMP-7 short peptides for nanostructured biomaterial applications

21 January 2018

1 reference

Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery

21 January 2018

1 reference

Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres

21 January 2018

1 reference

Murine preosteoblast differentiation induced by a peptide derived from bone morphogenetic proteins-9.

21 January 2018

1 reference

The evaluation of ectopic bone formation induced by delivery systems for bone morphogenetic protein-9 or its derived peptide.

21 January 2018

1 reference

The identification of a heparin binding domain peptide from bone morphogenetic protein-4 and its role on osteogenesis.

21 January 2018

1 reference

The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts

21 January 2018

1 reference

Growth hormone, insulin-like growth factors, and the skeleton

21 January 2018

1 reference

Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro

21 January 2018

1 reference

Bone morphogenetic proteins, their antagonists, and the skeleton

21 January 2018

1 reference

Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis

21 January 2018

1 reference

The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

21 January 2018

1 reference

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

21 January 2018

1 reference

The role of ghrelin in the control of energy balance

21 January 2018

1 reference

Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin

21 January 2018

1 reference

Targeting the ghrelin receptor to regulate food intake

21 January 2018

1 reference

Genetic determination of the cellular basis of the ghrelin-dependent bone remodeling

21 January 2018

1 reference

Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.

21 January 2018

1 reference

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

21 January 2018

1 reference

Ghrelin inhibits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway

21 January 2018

1 reference

Ghrelin directly regulates bone formation.

21 January 2018

1 reference

Chronic central administration of Ghrelin increases bone mass through a mechanism independent of appetite regulation.

21 January 2018

1 reference

Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects.

21 January 2018

1 reference

Stimulation of intramembranous bone repair in rats by ghrelin.

21 January 2018

1 reference

Ghrelin is an Osteoblast Mitogen and Increases Osteoclastic Bone Resorption In Vitro

21 January 2018

1 reference

Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a

21 January 2018

1 reference

Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.

21 January 2018

1 reference

Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides

21 January 2018

1 reference

Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor

21 January 2018

1 reference

Characterization of new stable ghrelin analogs with prolonged orexigenic potency

21 January 2018

1 reference

Sixteen weeks of hexarelin therapy in aged dogs: effects on the somatotropic axis, muscle morphology, and bone metabolism

21 January 2018

1 reference

Ghrelin regulates proliferation and differentiation of osteoblastic cells.

21 January 2018

1 reference

Metabolism of growth hormone releasing peptides

21 January 2018

1 reference

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats

21 January 2018

1 reference

The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats

21 January 2018

1 reference

Ipamorelin, the first selective growth hormone secretagogue

21 January 2018

1 reference

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

21 January 2018

1 reference

Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria

21 January 2018

1 reference

Amylin and adrenomedullin: novel regulators of bone growth.

21 January 2018

1 reference

Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice

21 January 2018

1 reference

Amylin and bone metabolism in streptozotocin-induced diabetic rats

21 January 2018

1 reference

Amylin fasting plasma levels are decreased in patients with osteoporosis

21 January 2018

1 reference

Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa

21 January 2018

1 reference

Amylin(1-8) is devoid of anabolic activity in bone

21 January 2018

1 reference

How to blast osteoblasts? Novel dicarba analogues of amylin-(1-8) to treat osteoporosis

21 January 2018

1 reference

Preptin analogues: chemical synthesis, secondary structure and biological studies

21 January 2018

1 reference

Lower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formation

21 January 2018

1 reference

Effects and differentiation activity of IGF-I, IGF-II, insulin and preptin on human primary bone cells.

21 January 2018

1 reference

Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts

21 January 2018

1 reference

Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus

21 January 2018

1 reference

The association between the serum C-peptide level and bone mineral density

21 January 2018

1 reference

Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes

21 January 2018

1 reference

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

21 January 2018

1 reference

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

21 January 2018

1 reference

Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs.

21 January 2018

1 reference

Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"

21 January 2018

1 reference

Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice

21 January 2018

1 reference

Correlation between induction of expression of biglycan and mineralization by C-type natriuretic peptide in osteoblastic cells.

21 January 2018

1 reference

Stimulation by retinoids of the natriuretic peptide system of osteoblastic MC3T3-E1 cells.

21 January 2018

1 reference

Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

How cells read TGF-beta signals

21 January 2018

1 reference

Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.

21 January 2018

1 reference

The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging

21 January 2018

1 reference

C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways

21 January 2018

1 reference

Dwarfism and early death in mice lacking C-type natriuretic peptide

21 January 2018

1 reference

Skeletal analysis of the long bone abnormality (lbab/lbab) mouse, a novel chondrodysplastic C-type natriuretic peptide mutant.

21 January 2018

1 reference

Differential effects of natriuretic peptide stimulation on tissue-engineered cartilage.

21 January 2018

1 reference

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis

21 January 2018

1 reference

Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias

21 January 2018

1 reference

C-type natriuretic peptide: Structural studies, fragment synthesis, and preliminary biological evaluation in human osteosarcoma cell lines.

21 January 2018

1 reference

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism

21 January 2018

1 reference

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia

21 January 2018

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

Endothelin and post-ganglionic sympathetic neurons

21 January 2018

1 reference

Gene expression of bone matrix proteins and endothelin receptors in endothelin-1-deficient mice revealed by in situ hybridization.

21 January 2018

1 reference

ETA receptor mediates the signaling of endothelin-1 in osteoblast-like cells

21 January 2018

1 reference

Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures

21 January 2018

1 reference

Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation

21 January 2018

1 reference

Postmenopausal women with osteoporosis may be associated with high endothelin-1.

21 January 2018

1 reference

Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate

21 January 2018

1 reference

Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells

21 January 2018

1 reference

Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.

21 January 2018

1 reference

Changes in pituitary adenylate cyclase-activating Peptide 27-like immunoreactive nervous structures in the porcine descending colon during selected pathological processes

21 January 2018

1 reference

Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line.

21 January 2018

1 reference

Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers.

21 January 2018

1 reference

Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules

21 January 2018

1 reference

Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication.

21 January 2018

1 reference

Neuropeptides stimulate human osteoblast activity and promote gap junctional intercellular communication.

21 January 2018

1 reference

cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells

21 January 2018

1 reference

The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts

21 January 2018

1 reference

Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors

21 January 2018

1 reference

Substance P activates the Wnt signal transduction pathway and enhances the differentiation of mouse preosteoblastic MC3T3-E1 cells

21 January 2018

1 reference

Neuropeptide substance P improves osteoblastic and angiogenic differentiation capacity of bone marrow stem cells in vitro

21 January 2018

1 reference

Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro

21 January 2018

1 reference

Human Galanin: Molecular Cloning Reveals a Unique Structure

21 January 2018

1 reference

Galanin receptor subtypes

21 January 2018

1 reference

Expression of galanin and a galanin receptor in several sensory systems and bone anlage of rat embryos

21 January 2018

1 reference

Presence of galanin-like immunoreactivity in mesenchymal and neural crest origin tissues during embryonic development in the mouse.

21 January 2018

1 reference

Expression of galanin and galanin receptor-1 in normal bone and during fracture repair in the rat

21 January 2018

1 reference

Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal

21 January 2018

1 reference

The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness

21 January 2018

1 reference

Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action

21 January 2018

1 reference

Structure-activity studies of orexin a and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands

21 January 2018

1 reference

Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen

21 January 2018

1 reference

Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen

21 January 2018

1 reference

Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels

21 January 2018

1 reference

A study of biologically active peptide sequences (P-15) on the surface of an ABM scaffold (PepGen P-15) using AFM and FTIR.

21 January 2018

1 reference

P-15 small peptide bone graft substitute in the treatment of non-unions and delayed union. A pilot clinical trial

21 January 2018

1 reference

Effects of P-15 Peptide Coated Hydroxyapatite on Tibial Defect Repair In Vivo in Normal and Osteoporotic Rats

21 January 2018

1 reference

Osteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivo

21 January 2018

1 reference

Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results.

21 January 2018

1 reference

Biomimetic surface modification using synthetic oligopeptides for enhanced guided bone regeneration in beagles.

21 January 2018

1 reference

Immobilization of a bone and cartilage stimulating peptide to a synthetic bone graft

21 January 2018

1 reference

Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation

21 January 2018

1 reference

An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation

21 January 2018

1 reference

Early gene and protein expression associated with osteoblast differentiation in response to fish collagen peptides powder

21 January 2018

1 reference

Early osteogenic differentiation of mouse preosteoblasts induced by collagen-derived DGEA-peptide on nanofibrous phage tissue matrices.

21 January 2018

1 reference

The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces

21 January 2018

1 reference

Potential impact of sitagliptin on collagen-derived dipeptides in diabetic osteoporosis.

21 January 2018

1 reference

Collagen-derived dipeptide prolyl-hydroxyproline promotes differentiation of MC3T3-E1 osteoblastic cells

21 January 2018

1 reference

Assembly of collagen-binding peptide with collagen as a bioactive scaffold for osteogenesis in vitro and in vivo

21 January 2018

1 reference

Injectable gel with synthetic collagen-binding peptide for enhanced osteogenesis in vitro and in vivo.

21 January 2018

1 reference

A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

Selective osteogenesis by a synthetic mineral inducing peptide for the treatment of osteoporosis

21 January 2018

1 reference

Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide.

21 January 2018

1 reference

Enhanced osteogenesis by collagen-binding peptide from bone sialoprotein in vitro and in vivo

21 January 2018

1 reference

Targeting integrins to promote bone formation and repair

21 January 2018

1 reference

Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial and long-bone defects

21 January 2018

1 reference

Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis.

21 January 2018

1 reference

Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library.

21 January 2018

1 reference

Peptide-based activation of alpha5 integrin for promoting osteogenesis.

21 January 2018

1 reference

Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells

21 January 2018

1 reference

Osteogenic differentiation of human mesenchymal stem cells on α5 integrin binding peptide hydrogels is dependent on substrate elasticity

21 January 2018

1 reference

Tailored integrin-extracellular matrix interactions to direct human mesenchymal stem cell differentiation

21 January 2018

1 reference

ASARM-truncated MEPE and AC-100 enhance osteogenesis by promoting osteoprogenitor adhesion.

21 January 2018

1 reference

MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia

21 January 2018

1 reference

MEPE has the properties of an osteoblastic phosphatonin and minhibin.

21 January 2018

1 reference

A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo

21 January 2018

1 reference

A fragment of the hypophosphatemic factor, MEPE, requires inducible cyclooxygenase-2 to exert potent anabolic effects on normal human marrow osteoblast precursors

21 January 2018

1 reference

Dentonin, a fragment of MEPE, enhanced dental pulp stem cell proliferation

21 January 2018

1 reference

Surface immobilization of MEPE peptide onto HA/β-TCP ceramic particles enhances bone regeneration and remodeling.

21 January 2018

1 reference

Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch.

21 January 2018

1 reference

Mechanical signals, IGF-I gene splicing, and muscle adaptation

21 January 2018

1 reference

Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation.

21 January 2018

1 reference

Expression and Splicing of the Insulin‐Like Growth Factor Gene in Rodent Muscle is Associated with Muscle Satellite (stem) Cell Activation following Local Tissue Damage

21 January 2018

1 reference

IGF-IEc expression, regulation and biological function in different tissues

21 January 2018

1 reference

The nuclear localization of MGF receptor in osteoblasts under mechanical stimulation

21 January 2018

1 reference

Mechano growth factor E peptide promotes osteoblasts proliferation and bone-defect healing in rabbits

21 January 2018

1 reference

Mechano-growth factor E peptide inhibits the differentiation and mineralization of osteoblasts

21 January 2018

1 reference

In vitro cytocompatibility evaluation of MGF-Ct24E chemically grafted and physically blended with maleic anhydride modified poly(D, L-lactic acid).

21 January 2018

1 reference

Functional and transcriptomic analysis of the regulation of osteoblasts by mechano-growth factor E peptide

21 January 2018

1 reference

Improving the osteogenic efficacy of BMP2 with mechano growth factor by regulating the signaling events in BMP pathway

21 January 2018

1 reference

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

21 January 2018

1 reference

Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum

21 January 2018

1 reference

Characterization of apelin, the ligand for the APJ receptor

21 January 2018

1 reference

Apelin and its receptor are expressed in human osteoblasts

21 January 2018

1 reference

Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways.

21 January 2018

1 reference

Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women

21 January 2018

1 reference

Increased bone mass in mice lacking the adipokine apelin

21 January 2018

1 reference

Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis

21 January 2018

1 reference

New cyclic peptides with osteoblastic proliferative activity from Dianthus superbus

21 January 2018

1 reference

Human alpha 2-macroglobulin is an osteogenic growth peptide-binding protein

21 January 2018

1 reference

Osteogenic growth peptide modulates fracture callus structural and mechanical properties

21 January 2018

1 reference

Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo

21 January 2018

1 reference

Biological designer self-assembling peptide nanofiber scaffolds significantly enhance osteoblast proliferation, differentiation and 3-D migration

21 January 2018

1 reference

Osteogenic growth peptide incorporated into PLGA scaffolds accelerates healing of segmental long bone defects in rabbits.

21 January 2018

1 reference

Osteogenic growth peptide enhances the proliferation of bone marrow mesenchymal stem cells from osteoprotegerin-deficient mice by CDK2/cyclin A.

21 January 2018

1 reference

Synthetic osteogenic growth peptide promotes differentiation of human bone marrow mesenchymal stem cells to osteoblasts via RhoA/ROCK pathway.

21 January 2018

1 reference

Mitogenic action of osteogenic growth peptide (OGP): role of amino and carboxy-terminal regions and charge

21 January 2018

1 reference

Mitogenic G(i) protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)] and attenuation of activation by cAMP.

21 January 2018

1 reference

Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes

21 January 2018

1 reference

Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10-14).

21 January 2018

1 reference

The use of immobilized osteogenic growth peptide on gradient substrates synthesized via click chemistry to enhance MC3T3-E1 osteoblast proliferation.

21 January 2018

1 reference

Egg yolk soluble protein stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

Protective effect of egg yolk peptide on bone metabolism

21 January 2018

1 reference

Effects of egg yolk-derived peptide on osteogenic gene expression and MAPK activation.

21 January 2018

1 reference

MAP kinase signaling cascades and gene expression in osteoblasts.

21 January 2018

1 reference

Antiosteoporotic effect of orally administered yolk-derived peptides on bone mass in women

21 January 2018

1 reference

rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells.

21 January 2018

1 reference

Bone formation is enhanced by thrombin-related peptide TP508 during distraction osteogenesis.

21 January 2018

1 reference

21 January 2018

1 reference

Repair of rabbit segmental defects with the thrombin peptide, TP508.

21 January 2018

1 reference

Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo.

21 January 2018

1 reference

Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles-enhanced bone formation during distraction osteogenesis.

21 January 2018

1 reference

Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues

21 January 2018

1 reference

Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

N-formyl-methionyl-leucyl-phenylalanine (fMLP) promotes osteoblast differentiation via the N-formyl peptide receptor 1-mediated signaling pathway in human mesenchymal stem cells from bone marrow

21 January 2018

1 reference

Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action.

21 January 2018

1 reference

Iron homeostasis in osteoporosis and its clinical implications

21 January 2018

1 reference

Hepcidin deficiency undermines bone load-bearing capacity through inducing iron overload

21 January 2018

1 reference

Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates.

21 January 2018

1 reference

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

Hepcidin increases intracellular Ca2+ of osteoblast hFOB1.19 through L-type Ca2+ channels

21 January 2018

1 reference

Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration

21 January 2018

1 reference

Casein kinase 2 beta-subunit is a regulator of bone morphogenetic protein 2 signaling

21 January 2018

1 reference

Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia.

21 January 2018

1 reference

Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro

21 January 2018

1 reference

E3 Ubiquitin Ligase Smurf1 Mediates Core-binding Factor α1/Runx2 Degradation and Plays A Specific Role in Osteoblast Differentiation

21 January 2018

1 reference

Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib

21 January 2018

1 reference

Proteasome inhibitors in the treatment of multiple myeloma

21 January 2018

1 reference

Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

21 January 2018

1 reference

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

21 January 2018

1 reference

Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling

21 January 2018

1 reference

The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling

21 January 2018

1 reference

Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function

21 January 2018

1 reference

Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions

21 January 2018

1 reference

HDAC4 integrates PTH and sympathetic signaling in osteoblasts

21 January 2018

1 reference

Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.

21 January 2018

1 reference

Regulation of bone mass by Wnt signaling

21 January 2018

1 reference

The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects.

21 January 2018

1 reference

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

21 January 2018

1 reference

Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients

21 January 2018

1 reference

Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma

21 January 2018

1 reference

Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation

21 January 2018

1 reference

The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway

21 January 2018

1 reference

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome

21 January 2018

1 reference

Central and peripheral expression of galanin in response to inflammation

21 January 2018

1 reference

Molecular Basis of Ligand Recognition by Integrin α5β1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.21388

1 reference

7 September 2017

1 reference

PubMed ID

27297498